Related Experiment Video
Updated: Mar 27, 2026
06:33
Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
Published on: June 9, 2018
8.2K
[Alpha-1 antitrypsin deficiency 50 years later]
Bulletin De L'Academie Nationale De Medecine
|January 13, 2016
Summary
Alpha-1 antitrypsin deficiency is a common genetic disorder causing lung and liver disease. New strategies targeting protein misfolding offer hope for slowing disease progression beyond current therapies.
Area of Science:
- Genetics
- Molecular Biology
- Pulmonology
- Hepatology
Context:
- Alpha-1 antitrypsin deficiency is a prevalent genetic disorder.
- It is linked to pulmonary emphysema in smokers and liver cirrhosis.
- Current treatments include lung/liver transplantation and replacement therapy.
Purpose:
- To review the pathogenesis of Alpha-1 antitrypsin deficiency.
- To explore novel therapeutic strategies.
- To highlight the underdiagnosis of this condition.
Summary:
- The disorder involves protein misfolding and endoplasmic reticulum (RER) aggregation.
- Proteostasis control is an emerging therapeutic strategy.
- Alpha-1 antitrypsin deficiency is frequently underdiagnosed.
Impact:
- Advances in understanding pathogenesis are paving the way for new treatments.
- Proteostasis control offers a potential new avenue for managing the disease.
- Increased awareness and diagnosis are crucial for patient management.
